Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
NCT00604435
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
docetaxel and epirubicin
DRUG:
docetaxel and epirubicin plus endostatin
Sponsor
Xijing Hospital